abrdn Life Sciences Investors - Common (HQL)

CUSIP: 87911K100

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common
Shares outstanding
29,948,325
Total 13F shares
6,434,689
Share change
+916,739
Total reported value
$80,230,199
Price per share
$12.47
Number of holders
79
Value change
+$11,333,847
Number of buys
43
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 87911K100?
CUSIP 87911K100 identifies HQL - abrdn Life Sciences Investors - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q3 2023

As of 30 Sep 2023, abrdn Life Sciences Investors - Common (HQL) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,434,689 shares. The largest 10 holders included MORGAN STANLEY, 1607 Capital Partners, LLC, Allspring Global Investments Holdings, LLC, RPO LLC, WOLVERINE ASSET MANAGEMENT LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, Cornerstone Advisors, LLC, AQR Arbitrage LLC, Saba Capital Management, L.P., and Logan Stone Capital, LLC. This page lists 79 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.